695 related articles for article (PubMed ID: 12575526)
1. FDA user fee and Modernisation Act.
Donawa M
Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
[TBL] [Abstract][Full Text] [Related]
2. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
3. Medical device technology user fees.
Bailey PG
Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
[TBL] [Abstract][Full Text] [Related]
4. New FDA draft guidance on premarket submissions.
Donawa ME
Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
[TBL] [Abstract][Full Text] [Related]
5. Will new FDA rules hasten device approval?
Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
[No Abstract] [Full Text] [Related]
6. New lease on life: device re-use gets legitimized. Illinois state senator led push to regulate 'secret' industry of reconditioned devices.
Becker C
Mod Healthc; 2002 Jan; 32(4):44-5. PubMed ID: 11859549
[No Abstract] [Full Text] [Related]
7. An important step forward in the global harmonisation of premarket review programmes.
Donawa M
Med Device Technol; 2001 Sep; 12(7):28-30. PubMed ID: 12938557
[TBL] [Abstract][Full Text] [Related]
8. How do regulatory agencies ensure the release of a safe medical device?
Haggar B
Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561
[TBL] [Abstract][Full Text] [Related]
9. FDA pilot programme in support of global harmonisation.
Donawa ME
Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
[TBL] [Abstract][Full Text] [Related]
10. Strategic planning for U.S. premarket approval submissions.
Donawa M
Med Device Technol; 2006 Sep; 17(7):21-3. PubMed ID: 17039953
[TBL] [Abstract][Full Text] [Related]
11. Familiar arguments: debate over device user-fee act reflects FDA's record.
Lee J
Mod Healthc; 2012 Apr; 42(14):16. PubMed ID: 22533178
[No Abstract] [Full Text] [Related]
12. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
13. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
[TBL] [Abstract][Full Text] [Related]
14. User fees and medical device reviews.
Lewis C
FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765
[No Abstract] [Full Text] [Related]
15. The new FDA combination products programme.
Donawa M
Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
[TBL] [Abstract][Full Text] [Related]
16. ECRI comments on FDA's reuse plan.
Healthc Hazard Manage Monit; 2000 Jun; 13(10):4-5. PubMed ID: 11125912
[No Abstract] [Full Text] [Related]
17. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
[TBL] [Abstract][Full Text] [Related]
18. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
19. Medical devices on trial, Part I.
Wright D
Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
[TBL] [Abstract][Full Text] [Related]
20. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
